SpringWorks Therapeutics Inc
NASDAQ:SWTX

Watchlist Manager
SpringWorks Therapeutics Inc Logo
SpringWorks Therapeutics Inc
NASDAQ:SWTX
Watchlist
Price: 46.99 USD 0.02% Market Closed
Market Cap: 3.5B USD

Wall Street
Price Targets

SWTX Price Targets Summary
SpringWorks Therapeutics Inc

There are no price targets for SWTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
SpringWorks Therapeutics Inc Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
370% Upside
FHTX
Foghorn Therapeutics Inc.
131% Upside
9966
Alphamab Oncology
3% Upside
IMDX
Insight Molecular Diagnostics Inc
3% Downside
ORY
Oryzon Genomics SA
132% Upside
INCY
Incyte Corp
5% Downside
688687
Beijing Kawin Technology Share-holding Co Ltd
86% Upside
ABOS
Acumen Pharmaceuticals Inc
233% Upside

Revenue
Forecast

Revenue Estimate
SpringWorks Therapeutics Inc

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 61%.

N/A
Past Growth
61%
Estimated Growth
Estimates Accuracy
95%
Average Beat

Operating Income
Forecast

Operating Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SWTX's stock price target?
Not Available

SWTX doesn't have any price targets made by Wall Street professionals.

What is SpringWorks Therapeutics Inc's Revenue forecast?
Projected CAGR
61%

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 61%.

Back to Top